IRIS
PURRELLO, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.977
EU - Europa 9.478
AS - Asia 8.550
SA - Sud America 1.680
AF - Africa 1.177
Continente sconosciuto - Info sul continente non disponibili 633
OC - Oceania 23
Totale 39.518
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.314
SG - Singapore 4.341
RU - Federazione Russa 2.763
IT - Italia 2.497
CN - Cina 2.085
BR - Brasile 1.396
IE - Irlanda 1.304
UA - Ucraina 1.030
VN - Vietnam 775
CI - Costa d'Avorio 588
CA - Canada 497
FR - Francia 456
SE - Svezia 324
IN - India 322
DE - Germania 276
GB - Regno Unito 225
NG - Nigeria 205
KR - Corea 204
SN - Senegal 201
BD - Bangladesh 183
NL - Olanda 109
AR - Argentina 90
FI - Finlandia 84
PL - Polonia 83
HK - Hong Kong 79
TR - Turchia 76
JP - Giappone 72
MX - Messico 72
ZA - Sudafrica 71
IQ - Iraq 57
UZ - Uzbekistan 55
ES - Italia 53
EC - Ecuador 47
CH - Svizzera 46
CO - Colombia 46
AT - Austria 42
PK - Pakistan 36
ID - Indonesia 31
IR - Iran 31
VE - Venezuela 31
GR - Grecia 27
MA - Marocco 27
CL - Cile 26
LB - Libano 26
CZ - Repubblica Ceca 22
KE - Kenya 22
SA - Arabia Saudita 22
LT - Lituania 21
AU - Australia 20
BE - Belgio 19
JM - Giamaica 19
TH - Thailandia 16
PH - Filippine 15
BJ - Benin 14
CR - Costa Rica 14
AZ - Azerbaigian 13
EG - Egitto 13
PY - Paraguay 13
RO - Romania 13
BG - Bulgaria 12
JO - Giordania 12
OM - Oman 12
AL - Albania 11
EU - Europa 11
PA - Panama 11
PE - Perù 11
TN - Tunisia 11
UY - Uruguay 11
NP - Nepal 10
AE - Emirati Arabi Uniti 9
HN - Honduras 9
HR - Croazia 9
IL - Israele 9
KZ - Kazakistan 9
MY - Malesia 9
BO - Bolivia 8
KW - Kuwait 8
DZ - Algeria 7
HU - Ungheria 7
KG - Kirghizistan 7
PS - Palestinian Territory 7
RS - Serbia 7
SV - El Salvador 7
ET - Etiopia 6
TT - Trinidad e Tobago 6
BH - Bahrain 5
NI - Nicaragua 5
DO - Repubblica Dominicana 4
GE - Georgia 4
GT - Guatemala 4
IS - Islanda 4
MK - Macedonia 4
PT - Portogallo 4
SI - Slovenia 4
BA - Bosnia-Erzegovina 3
DK - Danimarca 3
GD - Grenada 3
LV - Lettonia 3
NZ - Nuova Zelanda 3
SK - Slovacchia (Repubblica Slovacca) 3
Totale 38.851
Salva come PNG Salva come JPEG
Città #
Dallas 2.725
Singapore 2.558
Santa Clara 1.888
Chandler 1.403
Dublin 1.298
San Jose 1.263
Moscow 1.131
Jacksonville 1.068
Ashburn 856
Chicago 610
Abidjan 588
Boardman 546
Catania 377
Lawrence 356
Cambridge 355
Council Bluffs 350
Andover 347
Lauterbourg 343
Nanjing 341
Beijing 331
Los Angeles 323
Toronto 298
Hefei 292
Ho Chi Minh City 256
Civitanova Marche 252
Wilmington 222
Dakar 201
Seoul 201
Rome 197
Des Moines 192
Milan 179
Kochi 176
New York 172
San Mateo 167
Hanoi 162
São Paulo 125
Abuja 102
Buffalo 101
Nanchang 100
Shenyang 95
Palermo 94
Houston 93
Padova 88
Hebei 86
Lagos 78
The Dalles 78
Saint Petersburg 72
Hong Kong 68
Ottawa 68
Dong Ket 67
Jiaxing 67
Montreal 67
Tokyo 65
Orem 64
Warsaw 64
Columbus 63
Munich 60
Bremen 55
Phoenix 52
Brooklyn 50
Changsha 48
Johannesburg 47
Atlanta 46
Grafing 45
Rio de Janeiro 44
San Francisco 44
Denver 43
Stockholm 43
Tianjin 43
London 42
Naples 40
Amsterdam 38
Belo Horizonte 36
Chennai 36
Helsinki 35
Seattle 35
Da Nang 34
Boston 33
Lappeenranta 32
Istanbul 31
Poplar 31
Brasília 30
Frankfurt am Main 27
Tashkent 26
Manchester 25
Messina 25
Washington 24
Port Harcourt 23
Pune 23
Redondo Beach 23
San Giovanni la Punta 23
Augusta 22
Dhaka 22
Kunming 22
Mexico City 22
Carrara 21
Shanghai 21
Den Haag 20
Bari 19
Boydton 19
Totale 25.209
Salva come PNG Salva come JPEG
Nome #
IL DIABETE MELLITO AUMENTA LE RESISTENZE ARTERIOSE RENALI NEI PAZIENTI CON CIRROSI EPATICA 718
Long-term preservation of kidney function with SGLT-2 inhibitors versus comparator drugs in people with type 2 diabetes and chronic kidney disease 404
Il Rasario. Semeiotica medica 373
Criteri IDF e ATP-III per la diagnosi di sindrome metabolica: relazione con la prevalenza di steatosi epatica 278
Analysis of arterial stiffness and sexual function after adding on pcsk9 inhibitor treatment in male patients with familial hypercholesterolemia: A single lipid center real-world experience 269
1 h Postload Glycemia Is Associated with Low Endogenous Secretory Receptor for Advanced Glycation End Product Levels and Early Markers of Cardiovascular Disease 266
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 226
Critical appraisal of the European Union Scientific Committee on Health, Environmental, and Emergency Risks (SCHEER) Preliminary Opinion on electronic cigarettes 223
Controlling Nutritional Status (CONUT) Score as a Potential Prognostic Indicator of In-Hospital Mortality, Sepsis and Length of Stay in an Internal Medicine Department 209
An Uncharacterised lncRNA Coded by the ASAP1 Locus Is Downregulated in Serum of Type 2 Diabetes Mellitus Patients 194
The impact of SLCO1B1 rs4149056 on LDL-C target achievement after lipid lowering therapy optimization in men and women with familial hypercholesterolemia 193
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 191
Chronic exposure to palmitate impairs insulin signaling in an intestinal L-cell line: A possible shift from GLP-1 to glucagon production 177
Evaluations of metabolic and innate immunity profiles in subjects with familial hypercholesterolemia with or without subclinical atherosclerosis 174
Cellular and molecular effects of protons: Apoptosis induction and potential implications for cancer therapy 174
A ten-year (1989-1998) perspective study of the incidence of Type 1 diabetes in the district of Catania (Sicily) in a 0-14 year age group 173
Author Correction: Atorvastatin but Not Pravastatin Impairs Mitochondrial Function in Human Pancreatic Islets and Rat β-Cells. Direct Effect of Oxidative Stress 171
A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets 170
Atorvastatin but not pravastatin impairs mitochondrial function in human pancreatic islets and rat β-cells. Direct effect of oxidative stress 168
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 168
Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study 167
Abnormalities of Lipoprotein Levels in Liver Cirrhosis: Clinical Relevance 167
COPPER ADDITION PREVENTS THE INHIBITORY EFFECTS OF INTERLEUKIN-1-BETA ON RAT PANCREATIC-ISLETS 166
Alpha- and beta-cell abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes 166
Analysis of HDL-microRNA panel in heterozygous familial hypercholesterolemia subjects with LDL receptor null or defective mutation 166
Altered expression of uncoupling protein 2 in GLP-1-producing cells after chronic high glucose exposure: implications for the pathogenesis of diabetes mellitus. 164
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 164
Antibiotic use and associated factors in a large sample of hospitalised older people 163
A Molecular Systems BioMedicine Approach to Diabetes: Characterization, Prioritization and Network Analysis of New Candidate Genes from the Apoptotic Machinery 158
Altered expression of miRNAs and methylation of their promoters are correlated in neuroblastoma 158
Chronic Exposure to GLP-1 Increases GLP-1 Synthesis and Release in a Pancreatic Alpha Cell Line (α-TC1): Evidence of a Direct Effect of GLP-1 on Pancreatic Alpha Cells 157
Analysis of S100A12 plasma levels in hyperlipidemic subjects with or without familial hypercholesterolemia 156
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 156
Cardiovascular risk and renal injury profile in subjects with type 2 diabetes and non-albuminuric diabetic kidney disease 154
A Molecular Systems BioMedicine Approach to Diabetes: Characterization, Prioritisation and Network Analysis of New Candidate Genes from the Apoptotic Machinery 154
A Molecular Systems BioMedicine Approach to Diabetes: Characterization, Prioritization and Network Analysis of New Candidate Genes from the Apoptotic Machinery 153
High intake of dietary advanced glycation end-products is associated with increased arterial stiffness and inflammation in subjects with type 2 diabetes 153
A Molecular Systems BioMedicine Approach to Diabetes: Characterization, Prioritization and Network Analysis of New Candidate Genes from the Apoptotic Machinery 152
Arterial stiffness improvement after adding on PCSK9 inhibitors or ezetimibe to high-intensity statins in patients with familial hypercholesterolemia: A Two-Lipid Center Real-World Experience 151
Evaluation of high-density lipoprotein-bound long non-coding RNAs in subjects with familial hypercholesterolaemia 150
Alterazioni lipidiche ed epatiche in soggetti con prediabete identificato in base all'emoglobina glicosilata 150
Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity 148
Analysis of steatosis biomarkers and inflammatory profile after adding on PCSK9 inhibitor treatment in familial hypercholesterolemia subjects with nonalcoholic fatty liver disease: a single lipid center real-world experience 148
Cardiovascular Risk Profile in Subjects With Prediabetes and New-Onset Type 2 Diabetes Identified by HbA1c According to American Diabetes Association Criteria 147
HbA1c identifies subjects with prediabetes and subclinical left ventricular diastolic dysfunction 147
An increased waist-to-hip ratio is a key determinant of atherosclerotic burden in overweight subjects 147
Circulating coding and long non-coding rnas as potential biomarkers of idiopathic pulmonary fibrosis 146
Acute hyperbilirubinemia determines an early subclinical renal damage: Evaluation of tubular biomarkers in cholemic nephropathy 146
A Molecular Systems BioMedicine Approach to Diabetes: Characterization, Prioritisation and Network Analysis of New Candidate Genes from the Apoptotic Machinery (AM) 145
A molecular systems biomedicine approach to Diabetes: characterization, prioritization and network analysis of new candidate genes from the apoptotic machinery 145
Clinical and molecular biomarkers for diagnosis and staging of nafld 144
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 144
Update on Diabetic Kidney Disease (DKD): Focus on Non-Albuminuric DKD and Cardiovascular Risk 143
296-3p, miR-298-5p and their downstream networks are causally involved in the higher resistance of mammalian pancreatic α cells to cytokine-induced apoptosis as compared to β cells 143
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 143
Glucagon as a therapeutic approach to severe hypoglycemia: After 100 years, is it still the antidote of insulin? 143
A consensus statement for the clinical use of the renal sodium-glucose co-transporter-2 inhibitor dapagliflozin in patients with type 2 diabetes mellitus 142
Alterazioni della funzione diastolica in pazienti con diabete tipo 2 neodiagnosticato 141
(2012). Specifically different microRNAs profiles provide new insights on the molecular mechanisms activated by cytotoxic proinflammatory cytokines in mammalian pancreatic alpha and beta cells 141
Heart failure and chronic kidney disease in a registry of internal medicine wards 141
Action of insulin at the nuclear envelope 140
Smoking and diabetes: Dangerous liaisons and confusing relationships 139
Direct effects of d-chiro-inositol on insulin signaling and glucagon secretion of pancreatic alpha cells 139
Impaired Glucagon Suppression And Reduced Insulin Sensitivity In Subjects With Prediabetes Undergoing Atorvastatin Therapy 138
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 137
Evaluation of glycemic status and subclinical atherosclerosis in familial hypercholesterolemia subjects with or without LDL receptor mutation 135
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 135
Different effects of glucose and glyburide on insulin secretion in rat pancreatic islets pre-exposed to interleukin-1β. Possible involvement of K+ and Ca2+ channels 134
Inflammation and ventricular-vascular coupling in hypertensive patients with metabolic syndrome 134
Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview 134
Analysis of gingival crevicular fluid biomarkers in patients with metabolic syndrome 134
Acidi grassi polinsaturi omega 3 (PUFA): studio pilota nella terapia della NAFDL 133
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 132
Trattamento dell’ipercolesterolemia nel soggetto con diabete mellito: Aggiornamento sugli approcci terapeutici 132
Malnutrition-Related Liver Steatosis, CONUT Score and Poor Clinical Outcomes in an Internal Medicine Department 132
A molecular Systems Medicine approach to Diabetes Mellitus pinpoints the molecular bases of the higher resistance to cytokine-induced apoptosis of mammalian pancreas α cells respect to β cells 131
Molecular Effects of Chronic Exposure to Palmitate in Intestinal Organoids: A New Model to Study Obesity and Diabetes 130
Transient impairment of thyroid function in newborn from an area of endemic goiter 130
ALTERAZIONI DELLA FUNZIONE DIASTOLICA IN PAZIENTI CON DIABETE DI TIPO 2 NEODIAGNOSTICATO 127
Anticorpi anti-GH in soggetti in trattamento con ormone della crescita: incidenza e possibile ruolo degli aggregati dell'ormone nella loro genesi 127
Glucose regulates both glucose transport and the glucose transporter gene expression in a hamster-derived pancreatic Beta-cell line (HIT) 126
Early phase insulin secretion is increased in subjects with normal fasting glucose and metabolic syndrome: a premature feature of beta-cell dysfunction 126
Effetti della glucotossicita' su una linea cellulare di L cellule intestinali (GLUTAg: Ruolo di UCP-2 126
Early effects of high-fat diet, extra-virgin olive oil and vitamin D in a sedentary rat model of non-alcoholic fatty liver disease. 126
Direct and indirect effects of sars-cov-2 pandemic in subjects with familial hypercholesterolemia: A single lipid-center real-world evaluation 126
Correlazione fra patologia tiroidea e presenza di anticorpi antitireoglobulina ed antimicrosomi tiroidei 125
Separate impact of metabolic syndrome and altered glucose tolerance on early markers of vascular injuries. 125
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 125
L’analogo dell’insulina Lispro riduce i picchi iperglicemici post-prandiali in soggetti con diabete tipo 2 124
New treatment options for lipid-lowering therapy in subjects with type 2 diabetes 124
Appropriateness of antiplatelet therapy for primary and secondary cardio- and cerebrovascular prevention in acutely hospitalized older people 123
Convective Dialysis Reduces Mortality Risk: Results From a Large Observational, Population-Based Analysis 123
High glomerular filtration rate is associated with impaired arterial stiffness and subendocardial viability ratio in prediabetic subjects 123
Acidi grassi polinsaturi omega 3 (PUFA): studio pilota nella terapia della NAFLD 122
L’induzione di apoptosi da parte di protoni suggerisce innovative strategie terapeutiche anticancro 121
.:FATTORI PROGNOSTICI DI GUARIGIONE DELLE ULCERE DEL PIEDE DIABETICO 121
Coffee Restores Expression of lncRNAs Involved in Steatosis and Fibrosis in a Mouse Model of NAFLD 121
Alterazioni molecolari del segnale insulinico e del metabolismo degli FFA in pazienti con NASH 120
Chronic exposure to glibenclamide impairs insulin secretion in isolated rat pancreatic islets 120
Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real-life setting: the PROSISA Study 120
Totale 16.128
Salva come PNG Salva come JPEG
Categoria #
all - tutte 137.778
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 137.778
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.005 0 0 17 66 427 58 377 102 218 11 103 626
2022/20234.336 386 200 65 417 406 742 23 802 1.023 30 149 93
2023/20242.049 110 308 103 116 86 440 39 169 23 63 341 251
2024/20258.501 736 1.188 466 499 1.607 852 294 272 520 760 758 549
2025/202616.117 924 693 3.023 1.085 2.428 3.085 1.949 345 789 879 475 442
2026/20271.213 308 590 315 0 0 0 0 0 0 0 0 0
Totale 39.518